tradingkey.logo
tradingkey.logo
검색

AxoGen Inc

AXGN
관심 목록에 추가
44.020USD
-2.170-4.70%
종가 07/01, 16:00ET시세는 15분 지연됩니다
2.08B시가총액
손실P/E TTM

자세한 내용은 AxoGen Inc 회사

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

AxoGen Inc 정보

종목 코드 AXGN
회사 이름AxoGen Inc
상장일Dec 17, 1986
CEODale (Michael Donald)
직원 수451
유형Ordinary Share
회계 연도 종료Dec 17
주소13631 Progress Blvd.
도시ALACHUA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호32615
전화13864626817
웹사이트https://www.axogeninc.com/
종목 코드 AXGN
상장일Dec 17, 1986
CEODale (Michael Donald)

AxoGen Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
65.15K
+6.77%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
64.95K
-6.16%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
28.93K
+65.23%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Dr. Joseph (Adrian) Tyndall, M.D.
Dr. Joseph (Adrian) Tyndall, M.D.
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
65.15K
+6.77%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
64.95K
-6.16%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
28.93K
+65.23%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--

자주 묻는 질문

AxoGen Inc의 상위 5대 주주는 누구인가요?

AxoGen Inc의 상위 5대 주주는 다음과 같습니다: Ms. Lindsey Hartley

AxoGen Inc(AXGN)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, AxoGen Inc의 주식을 보유한 기관은 총 399곳이며, 이들이 보유한 주식의 총 가치는 약 48.71M로 전체 발행 주식의 91.60%를 차지합니다. 이는 2025Q4 대비 3148593.00 증가한 수치입니다.